基本信息
views: 119
Career Trajectory
Bio
胡海燕,女,教授,博士生导师。从事新药研发及新型给药系统的研究。主持和完成多个新药研发项目,作为主要负责人参与研发的1.1类化学药安脑三醇注射剂已获临床批件,目前已经完成I期临床试验。主要研究方向:1)肿瘤靶向递药系统;2)菌膜靶向递药系统;3)生物大分子口服给药。在J Control Release、Mol Pharmaceut、J Neurosci、Carbohyd Polym、Int J Pharm、J Drug Target 上共发表学术论文30余篇,并获得10余项中国专利授权,其中两项获得包括美国、日本在内的多国专利授权。主持国家自然科学基金、“十二五”国家科技重大专项“重大新药创制”、广东省自然科学基金等多项国家及省部级课题。为Drug Delivery, Carbohyd Polym, Int J Pharm、Euro J Pharm Sci, APSB等杂志的特邀审稿人。《药学学报》青年编委, 中国药学会药剂学专委会青年委员,中国民族医药学会布朗医药分会常务理事。
Research Interests
Papers共 246 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Colloids and surfaces. B, Biointerfaces (2024): 113798-113798
Yingying Sun, Tianli Lu, Jieyi Pan, Haonan He,Mao Xu,Yujun Chen,Yan Chen,Pengchao Fang,Xiaoxing Ye,Shuxuan Li,Haiyan Hu,Shihui Yu
Colloids and Surfaces B: Biointerfaces (2024): 114088-114088
JOURNAL OF CONTROLLED RELEASE (2024): 219-235
Qing Zhang,Wenjun Hu,Mingxue Guo,Xinyu Zhang,Qin Zhang, Fengqi Peng, Liwen Yan, Zucheng Hu,Jakkree Tangthianchaichana,Yan Shen,Haiyan Hu,Shouying Du,
INTERNATIONAL JOURNAL OF NANOMEDICINE (2024): 53-71
ACTA PHARMACEUTICA SINICA Bno. 11 (2023): 4661-4663
Hehui Rong,Yating Dong,Junke Zhao, Xuefei Zhang,Shuxuan Li,Yingying Sun, Tianli Lu,Shihui Yu,Haiyan Hu
Acta Pharmaceutica Sinica B (2023)
Acta Scientiarum Naturalium Universitatis Sunyatsenino. 3 (2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn